RxDoctor Payments Data

Micah Howard, MD

Family Medicine · Decatur, ALNPI 1174834188

Payments from drug & device makers

$583in general payments, 2019–2025

Across 38 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$122
  • Sanofi-aventis U.S. LLC$51
  • Teva Pharmaceuticals USA, Inc.$50
  • Merck$45
  • Astellas Pharma US Inc$42
  • Abbott$41
  • plus $233 from 11 others

What the payments were for

  • Food & beverage$583100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$583 in reported general payments places this provider in the 45th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$112,082
Medicare patients
196
Services billed
2,050

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide75$91,637
OzempicSemaglutide77$90,214
EliquisApixaban52$44,531
RybelsusSemaglutide13$26,850
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog25$18,683
JanuviaSitagliptin Phosphate12$15,973
FarxigaDapagliflozin Propanediol21$14,684
XareltoRivaroxaban17$12,780
EntrestoSacubitril/Valsartan16$9,327
Tresiba Flextouch U-100Insulin Degludec11$7,959
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,992
JardianceEmpagliflozin12$4,946
Levothyroxine Sodium295$3,623
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen143$3,174
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,869

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$122$117,06490 claims
Lilly USA, LLCMounjaro$15$91,63775 claims
MerckJanuvia$45$15,97312 claims
Johnson & JohnsonXarelto$12$12,78017 claims
NovartisEntresto$20$9,32716 claims
GSKTrelegy Ellipta$12$6,99211 claims
Boehringer IngelheimJardiance$15$4,94612 claims
AbbVieSynthroid$38$2,26727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Decatur

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →